ESC 365 - Is the HNF4A gene variant paradoxically associated with better prognostic in CAD patients?

ESC Professional Premium Access

Is the HNF4A gene variant paradoxically associated with better prognostic in CAD patients?

Session: Cardiovascular disease: genetic determinants and molecular phenotyping

Topic: Pathophysiology and Mechanisms

Speaker: Doctor D. Sa (Funchal, PT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

0 follower

4 more presentations in this session

Circulating ACE2 and the association of endothelial progenitor cell in CAD patients

Speaker: Doctor Y. Lu (Taichung, TW)

Aspirin inhibits atherosclerosis through macrophage pyroptosis by interacting with Lactobacillus johnsonii and its metabolite butyrate

Speaker: Doctor H. Rui (Xi'an, CN)

Awareness and perceptions of cardiologists towards systemic inflammation in atherosclerotic cardiovascular disease: A multi-national survey across 5 geographical regional sub-groups

Speaker: Professor A. Catapano (Milan, IT)

Coronary Computed Tomographic Angiography (CCTA) in non-ST elevation acute coronary syndromes

Speaker: Doctor I. Chapman (Buenos Aires, AR)

Access the full session

Cardiovascular disease: genetic determinants and molecular phenotyping

Speakers: Doctor D. Sa, Doctor Y. Lu, Doctor H. Rui, Professor A. Catapano, Doctor I. Chapman

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources